ID: h-85753bf7db
Hypothesis
HBOT at 2.0 ATA for 60 min, 5x/week for 6 weeks enhances hippocampal neurogenesis via BDNF/TrkB signaling to improve memory consolidation
HBOT increases cerebral oxygen tension, creating a favorable microenvironment for NSC proliferation and upregulating BDNF transcription via HIF-1α stabilization, activating TrkB on progenitors.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 3 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
HBOT increases cerebral oxygen tension, creating a favorable microenvironment for NSC proliferation and upregulating BDNF transcription via HIF-1α stabilization, activating TrkB on progenitors. However, adult hippocampal neurogenesis in aged human AD is controversial, and increased BDNF after acute injury does not imply restored neurogenesis in chronic amyloid/tau disease.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["HBOT 2.0 ATA<br/>60 min 5x/week 6 weeks"]
B["BDNF<br/>Upregulation"]
C["TrkB<br/>Receptor Activation"]
D["Hippocampal<br/>Neurogenesis"]
E["Memory<br/>Consolidation"]
A --> B
B --> C
C --> D
D --> E
style A fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7
style E fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7⚖️ Evidence
⚖️ Evidence Matrix3 supports3 contradicts
Contradicts
Adult hippocampal neurogenesis in aged human AD is controversial and likely too limited
Contradicts
BDNF increase in acute injury models does not translate to chronic amyloid/tau disease
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — BDNF
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for BDNF from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for BDNF.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.3%
Volatility
Low
0.0164
Events (7d)
2
Price History
▲6.4%💾 Resource Usage
LLM Tokens
11,804
$0.0354
Total Cost
$0.0354
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF 12-month-old APP/PS1 mice receive HBOT at 2.0 ATA for 60 min, 5x/week for 6 weeks, THEN hippocampal DCX+ neuroblast density will increase by ≥40% and these mice will exhibit ≥20% better performance | DCX+ cell count in dentate gyrus subgranular zone will be ≥40% higher; probe trial platform crossings will be ≥20% greater in HBOT vs control group | — no observation — | pending | 0.62 |
| IF adults aged 55-70 with confirmed amyloid pathology (PET or CSF Aβ42/Aβ40 ratio) receive HBOT at 2.0 ATA for 60 min, 5x/week for 6 weeks (30 total sessions), THEN serum BDNF levels will increase by | Serum BDNF concentration will be ≥25% higher in HBOT group vs sham, with effect size d ≥ 0.6 | — no observation — | pending | 0.55 |
🔮 Falsifiable Predictions (2)
pendingconf 62%
IF 12-month-old APP/PS1 mice receive HBOT at 2.0 ATA for 60 min, 5x/week for 6 weeks, THEN hippocampal DCX+ neuroblast density will increase by ≥40% and these mice will exhibit ≥20% better performance on Morris water maze probe trial vs room air controls.
Predicted outcome: DCX+ cell count in dentate gyrus subgranular zone will be ≥40% higher; probe trial platform crossings will be ≥20% greater in HBOT vs control group
Falsification: DCX+ cell density does not differ significantly between HBOT and room air groups (p > 0.05) or Morris water maze probe trial performance is equivalent, indicating no functional neurogenesis improvemen
pendingconf 55%
IF adults aged 55-70 with confirmed amyloid pathology (PET or CSF Aβ42/Aβ40 ratio) receive HBOT at 2.0 ATA for 60 min, 5x/week for 6 weeks (30 total sessions), THEN serum BDNF levels will increase by ≥25% compared to sham HBOT controls (1.5 ATA room air) at 1 week post-intervention.
Predicted outcome: Serum BDNF concentration will be ≥25% higher in HBOT group vs sham, with effect size d ≥ 0.6
Falsification: Serum BDNF in HBOT group differs <25% from sham (p > 0.05) or shows no dose-response with protocol adherence
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.